Role of lipegfilgrastim in the management of chemotherapy-induced neutropenia [Corrigendum]
Hoggatt J, Tate TA, Pelus LM. Int J Nanomed. 2015;10:2647–2652.In this article, Lipegfilgrastim was referred to as a "long-acting biosimilar filgrastim". The term "biosimilar" was used too broadly in this case, as Lipegfilgrastim was not approved under t...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2015-08-01
|
| Series: | International Journal of Nanomedicine |
| Online Access: | http://www.dovepress.com/corrigendum-role-of-lipegfilgrastim-in-the-management-of-chemothe-peer-reviewed-article-IJN |